
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/">
  <dc:rights>http://creativecommons.org/licenses/by/2.0/at/legalcode</dc:rights>
  <dc:title xml:lang="srp">Preživljavanje pacijenata sa malignim tumorom gornjeg urotelijuma posle nefroureterektomije i faktori rizika za nastajanje malignog tumora mokraćne bešike  : doktorska disertacija</dc:title>
  <dc:format>PDF/A (91 list)</dc:format>
  <dc:format>2306696 bytes</dc:format>
  <dc:date>2012</dc:date>
  <dc:subject xml:lang="eng">OSNO - Opšta sistematizacija naučnih oblasti, Urologija</dc:subject>
  <dc:subject xml:lang="srp">OSNO - Opšta sistematizacija naučnih oblasti, Urologija</dc:subject>
  <dc:subject xml:lang="srp">tumor gornjeg urotelijuma, tumor mokraćne bešike, preživljavanje, prediktivni faktori, ureter, pijelon</dc:subject>
  <dc:subject xml:lang="eng">upper urinary tract urothelial carcinoma, bladder cancer, survival, predictive factors, ureter, renal pelvis</dc:subject>
  <dc:subject xml:lang="srp">616.6-006.6-089(043.3)</dc:subject>
  <dc:language>srp</dc:language>
  <dc:creator>Milojević, Bogomir D.</dc:creator>
  <dc:identifier>https://phaidrabg.bg.ac.rs/o:5465</dc:identifier>
  <dc:identifier>cobiss:42566415</dc:identifier>
  <dc:identifier>thesis:210</dc:identifier>
  <dc:type>info:eu-repo/semantics/bachelorThesis</dc:type>
  <dc:contributor>Đokić, Milan</dc:contributor>
  <dc:contributor>Šipetić-Grujičić, Sandra</dc:contributor>
  <dc:contributor>Milutinović, Drago</dc:contributor>
  <dc:contributor>Milenković-Petronić, Dragica</dc:contributor>
  <dc:contributor>Ilić, Milena</dc:contributor>
  <dc:description xml:lang="srp">Karcinomi gornjeg urotelijuma su retki, oni čine oko 5% urotelnih karcinoma. Tumori
pielokaliksnog sistema su oko 2 puta češći od tumora uretera. U prognostičke faktore za
tumore gornjeg urotelijuma navode se: patohistološki stadijum i gradus tumora,
limfovaskularna invazija, starost pacijenta, tumorska nekroza, kao i molekulski markeri.
Lokacija primarnog tumora (pijelon nasuprot uretera) predstavlja kontraverzni faktor
rizika. Tumori mokraćne bešike se javljaju u 15-50% pacijenata koji su operisani zbog
primarnog tumora gornjeg urotelijuma.
U ovoj studiji je ispitivan uticaj lokacije primarnog tumora gornjeg urotelijuma na pojavu
recidiva bolesti i preživljavanje kod pacijenata lečenih radikalnom nefroureterektomijom.
Analizirani su nezavisni faktori rizika za nastanak tumora mokraćne bešike kod operisanih
pacijenata zbog primarnog tumora gornjeg urotelijuma, kao i preživljavanje pacijenata sa
novonastalim malignim tumorom mokraćne bešike.
Sprovedena je kohortna retrospektivna studija u koju su uključeni operisani pacijenti zbog
tumora gornjeg urotelijuma u Klinici za urologiju Kliničkog centra Srbije u period od
1999-2009. godine. Inicijalno lečenje kod svih pacijenata je bilo hirurško i podrazumevalo
je radikalnu nefroureterektomiju i konzervirajuću operaciju tumora gornjeg urotelijuma. U
studijsku kohortu, u kojoj je ispitivan uticaj lokacije primarnog tumora gornjeg urotelijuma
na pojavu recidiva bolesti i preživljavanje, uključeni su samo pacijenti kojima je učinjena
radikalna nefroureterektomija. Isključeni su pacijenti koji su prethodno podvrgnuti
radikalnoj cistektomiji, preoperativnoj hemioterapiji i pacijenti koji su prethodno imali
kontralateralni tumor gornjeg urotelijuma. Tako da je konačnu studijsku populaciju činilo 133 pacijenta...</dc:description>
  <dc:description xml:lang="eng">Upper urinary tract urothelial carcinomas (UTUC) are relatively rare, accounting for 5% of
urothelial tumors. Tumors of the renal pelvis are about two times more common than
ureteral tumors. Pathological stage, tumor grade, lymphovascular invasion, patient age,
tumor necrosis, as well as molecular markers have been established as prognostic factors
for UTUC. The location of the primary tumor (renal pelvis vs ureter), however, represents
a controversial risk factor. Previous studies showed that 15–50% of patients operated for
UTUC have subsequent cancer development in the bladder.
The present study assessed the impact of tumor location on the disease recurrence and
survival of patients who were surgically treated for UTUC with nephroureterectomy. We
also attempted to identify independent risk factors for the development of bladder cancer
after surgical management of UTUC and to determine whether the development of bladder
cancer affects the survival of patients.
We performed a retrospective cohort study, which involved patients underwent surgery for
UTUC in the Department of Urology, Clinical Center of Serbia in the period 1999-2009.
Initial treatment for all patients was surgical and involved radical nephroureterectomy and
conservational surgery urinary tract tumors. In a study cohort of 133 patients were
included only patients who underwent radical nephroureterectomy. Patients who had
previously undergone radical cystectomy, preoperative chemotherapy or previous
contralateral UTUC were excluded. Hospital medical records from these 133 patients were
reviewed retrospectively to assess the significance of tumor location on disease recurrence
and survival...</dc:description>
  <dc:description xml:lang="srp">Epidemiologija - Urologija / Epidemiology - Urology 
Datum odbrane : 18.01.2013 </dc:description>
</oai_dc:dc>
